69 results on '"Puhan, Milo A."'
Search Results
2. Lung Cancer in Switzerland
3. A Living Benefit-Harm Modelling Study of Glp-1 Receptor Agonists for Weight Reduction in Non-Diabetic Obese and Overweight Individuals
4. Benefit-harm analysis for informed decision making on participating in colorectal cancer screening: a modelling study
5. Perioperative outcome assessment from the perspectives of different stakeholders: need for reconsideration?
6. Mechanisms and clinical relevance of the bidirectional relationship of viral infections with metabolic diseases
7. Post COVID-19 condition, work ability and occupational changes in a population-based cohort
8. Longitudinal humoral and cell-mediated immune responses in a population-based cohort in Zurich, Switzerland between March and June 2022 - evidence for protection against Omicron SARS-CoV-2 infection by neutralizing antibodies and spike-specific T-cell responses
9. Experiences of persons with multiple sclerosis with the Covid-19 vaccination: A cross-sectional study of the Swiss Multiple Sclerosis Registry
10. Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment
11. Older adult preferences regarding benefits and harms of statin and aspirin therapy for cardiovascular primary prevention
12. Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region
13. Mapping the landscape of lung cancer breath analysis: A scoping review (ELCABA)
14. Treatments for Metastatic Hormone-sensitive Prostate Cancer: Systematic Review, Network Meta-analysis, and Benefit-harm assessment
15. Effectiveness of a Long-term Home-Based Exercise Training Program in Patients With COPD After Pulmonary Rehabilitation
16. Travel behaviours and health outcomes during travel: Profiling destination-specific risks in a prospective mHealth cohort of Swiss travellers
17. Real-world disease-modifying therapy usage in persons with relapsing-remitting multiple sclerosis: Cross-sectional data from the Swiss Multiple Sclerosis Registry
18. Nationwide implementation of the self-management program “Living well with COPD”: Process and effectiveness evaluation using a mixed-methods approach
19. Mental Health of Individuals Infected With SARS-CoV-2 During Mandated Isolation and Compliance With Recommendations - A Population-Based Cohort Study
20. Personalising add-on treatment with inhaled corticosteroids in patients with chronic obstructive pulmonary disease: a benefit–harm modelling study
21. Los juicios personales ocultos y no controlados que surgen al manejar la EPOC basándose en el historial de exacerbaciones
22. Patterns of Physical Activity Progression in Patients With COPD
23. The Role of Mobility Endpoints in Marketing Authorisation of Drugs: What Gets the EMA Moving?
24. TOURIST2 – Tracking of urgent risks in swiss travellers to the 6 main travel destinations – Feasibility and ethical considerations of a smartphone application-based study
25. Benefit-harm balance of fingolimod in patients with MS: A modelling study based on FREEDOMS
26. Sex differences between women and men with COPD: A new analysis of the 3CIA study
27. Development and validation of the self-reported disability status scale (SRDSS) to estimate EDSS-categories
28. Informing Patient-Centered Care Through Stakeholder Engagement and Highly Stratified Quantitative Benefit–Harm Assessments
29. Impaired Sleep Quality in COPD Is Associated With Exacerbations
30. A benefit–harm analysis of adding basal insulin vs. sulfonylurea to metformin to manage type II diabetes mellitus in people with multiple chronic conditions
31. Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participants
32. Antidepressant prescription in acute myocardial infarction is associated with increased mortality 1 year after discharge
33. Patterns of care for Multiple Sclerosis in a setting of universal care access: A cross-sectional study
34. The disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most?
35. Cost-effectiveness of low-dose CT screening for lung cancer in a European country with high prevalence of smoking—A modelling study
36. Corrigendum to “Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis” [J Clin Epidemiol 2018;93:36-44]
37. Recommended outcome measures for inpatient rehabilitation of multiple sclerosis are not appropriate for the patients with substantially impaired mobility
38. Generalized spatial fusion model framework for joint analysis of point and areal data
39. Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis
40. Streaming data from a smartphone application: A new approach to mapping health during travel
41. Commonly Used Patient-Reported Outcomes Do Not Improve Prediction of COPD Exacerbations
42. The 1-min sit-to-stand test in cystic fibrosis — Insights into cardiorespiratory responses
43. Management and outcome of patients with acute myocardial infarction presenting with pacemaker rhythm
44. The Inaccuracy of Patient Recall for COPD Exacerbation Rate Estimation and Its Implications
45. Non-vector-borne transmission of Zika virus: A systematic review
46. Evidence selection for a prescription drug's benefit-harm assessment: challenges and recommendations
47. The 1-min sit-to-stand test—A simple functional capacity test in cystic fibrosis?
48. Pre-travel health advice guidelines for humanitarian workers: A systematic review
49. Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data
50. Sex Differences in Response to Tadalafil in Pulmonary Arterial Hypertension
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.